Pharmaceutical formulations comprising coated tablets
By preparing colored coated tablets, the problem of easy degradation of GDC-0077 under photo-stress conditions was solved, and the stability and manufacturability were improved, making it a highly efficient solid dosage form suitable for the treatment of PIK3CA mutant cancers.
CN122070126APending Publication Date: 2026-05-19F HOFFMANN LA ROCHE & CO AG +1
View PDF 5 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- F HOFFMANN LA ROCHE & CO AG
- Filing Date
- 2024-08-09
- Publication Date
- 2026-05-19
Smart Images

Figure CN122070126A_ABST
Abstract
The present invention relates to a pharmaceutical formulation in the form of a pharmaceutical formulation comprising GDC-0077 (enraliplug) or a salt thereof, said formulation having a colored coating.
Need to check novelty before this filing date? Find Prior Art